@article{article, title  = {{nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2018}},

 month = {{6}},

 author = {{Yardley DA and Coleman R and Conte P and Cortes J and Brufsky A and Shtivelband M and Young R and Bengala C and Ali H and Eakel J and Schneeweiss A et al}},

 doi = {{10.1093/annonc/mdy201}},

 volume = {{29}},

 journal = {{Annals of Oncology}},

 issue = {{8}},

 pages = {{1763-1770}},

 note = {{Accessed on 2025/10/10}}}